Forty-two athletes, most of them openly juiced on testosterone, anabolics, and peptides, gathered at a $50 million open-air stadium in Las Vegas over Memorial Day weekend to lift, swim, and sprint for prize money. The made-for-cameras event had a quieter commercial purpose. The Enhanced Games are the public face of Enhanced Group, a seller of peptides, hormones, and weight-loss drugs that began trading on the New York Stock Exchange this month at a $1.2 billion valuation, backed by Peter Thiel and other Silicon Valley investors.
The thing worth watching is not the lone world record set in the pool on May 24. It is a date on a federal regulator’s calendar in late July that could turn a Bay Area obsession with injectable peptides into a consumer business worth billions.
The $50 Million Billboard in the Desert
The competition itself looked like a sporting event and behaved like a commercial. Athletes received appearance fees just for showing up. Anyone who placed first or broke a world record stood to collect six or seven figures, with up to $1 million on offer for the 100 meter sprint and the 50 meter freestyle. The whole thing closed with a short set from The Killers.
Around 200 journalists were flown in, given a workspace, meals, and press time with executives. That generosity was not an accident. The reporters were the distribution channel, the people who would carry word of the spectacle back to a global audience and, by extension, advertise the products that pay for it.
- $50 million stadium with a track, pools, and a weightlifting pavilion, built in a matter of weeks at Resorts World Las Vegas
- $250,000 for a world-record attempt, with marquee prizes reaching $1 million
- $32 million in sponsorship value drawn from brands including Roku and Rumble
For all the buildup, the action mostly underwhelmed. The night produced a single world record, set by Greek swimmer Kristian Gkolomeev, who covered the 50 meter freestyle in 20.81 seconds, beating the previous mark by 0.07 seconds. The crowd roared, the lights flashed red, and chief executive Maximilian Martin rushed the pool deck in his suit to hug the winner.
Enhanced Group’s Path From Startup to NYSE Ticker
Enhanced was a private startup until early May. It went public through a merger with A Paradise Acquisition Corp, a SPAC (special purpose acquisition company, a shell that takes a private firm public without a traditional IPO), and began trading on the New York Stock Exchange under the ticker ENHA on May 8. The deal carried that headline price tag and the prospect of up to $200 million in gross cash proceeds. Shares jumped as much as 20% in early trading, according to the company’s NYSE trading announcement.
The games grab the headlines, but they are the smaller of two engines. The other is a consumer-health operation selling personalized protocols: peptides, testosterone injections, and GLP-1 (glucagon-like peptide-1 drugs, the class behind weight-loss shots like Ozempic) prescriptions for weight loss. The company recently tied that business to a telehealth platform built with Rezolve Ai, a digital storefront aimed at consumers who want to bulk up or look younger.
The people running it come from tech, not sport. Martin, 29, previously founded a bitcoin mining company. His co-founder and executive chairman, Christian Angermayer, is a German billionaire investor. Former Coinbase executive Balaji Srinivasan is among the backers. You can read the go-public business combination terms on the firm’s own site.
| Engine | The Enhanced Games | The consumer-health business |
|---|---|---|
| Purpose | Spectacle and brand awareness | Recurring product revenue |
| What it sells | Tickets, sponsorships, broadcast | Peptides, testosterone, GLP-1 prescriptions |
| Audience | Global media, sports fans | Adults seeking muscle, weight loss, longevity |
| Frequency | Annual event | Ongoing telehealth subscriptions |
The July Calendar Date the Valuation Hinges On
Strip away the showmanship and the investment case rests on regulation. A large share of the products Enhanced wants to sell at scale sit in a legal gray zone, and the government is about to revisit where the lines fall.
What the FDA Restricted in 2023
In September 2023, the Food and Drug Administration (FDA, the U.S. agency that regulates drugs) pulled a group of peptides from the list of substances compounding pharmacies were allowed to make, citing significant safety risks. That action pushed a chunk of demand toward overseas suppliers and unregulated sellers, the exact black market that Enhanced now says it wants to replace with supervised, prescribed alternatives.
What the Panel Weighs in July
The mood in Washington has shifted. In February, U.S. Health Secretary Robert F. Kennedy Jr. told podcaster Joe Rogan he was a “big fan” of peptides and signaled he wanted broader access. The FDA has now scheduled an advisory committee to meet on July 23 and 24 to weigh whether to reclassify several previously restricted peptides. The first session covers seven substances; a later meeting is expected to take up five more.
Among the compounds on the table:
- BPC-157, marketed for tissue and wound healing
- KPV, promoted for inflammation
- TB-500, used in recovery circles
- MOTS-c, pitched for metabolism and endurance
An advisory committee does not write law, and its recommendation is not binding. But a favorable vote would clear a path for companies to sell these peptides openly, and the startups racing to be first are pricing in exactly that outcome.
Why Silicon Valley Is Pouring Money Into Peptides
The Enhanced Games are the loudest sign of a quieter capital shift. In the Bay Area, peptides have become both a personal habit and an investment thesis, with elite clubs reportedly hosting injecting parties as use among the tech set climbs.
The Startups Raising Cash
Superpower, an AI longevity startup that sells FDA-approved peptides, has raised more than $30 million in a Series A round; its founder has floated peptides as a future $1 trillion category. Noho Labs, founded by former Coatue partner Matt Mazzeo, has pulled in roughly $16 million from investors including Elad Gil and 8VC, the fund tied to Palantir co-founder Joe Lonsdale, per the startup’s company funding profile.
The Culture Driving Demand
Demand is not confined to venture offices. Teenagers and twenty-somethings are turning to peptides to “looksmax,” the slang for any extreme effort at self-beautification, fueled by fitness influencers and podcasters who keep the topic in heavy rotation. Martin frames the opportunity in plain numbers, arguing the U.S. peptide market already reaches 85 million Americans mostly served by unsupervised, unregulated substances.
Angermayer is blunter about the motive.
I’m a capitalist. There is no reason why something that is good should not also be a business.
That was the executive chairman speaking to reporters in Las Vegas, and it captures the bet underneath the whole production: that wellness and profit point in the same direction.
The Gray-Market Risk Hanging Over the Boom
Health authorities see a different trajectory. The World Anti-Doping Agency has called the Enhanced Games “dangerous,” and Travis Tygart, chief executive of the U.S. Anti-Doping Agency, dismissed the event as a “clown show that puts profit over people.”
Their deeper worry is cultural rather than competitive. The drugs Enhanced sells are FDA-cleared, but critics argue that staging a celebrity-soaked spectacle around enhancement normalizes the behavior and nudges younger, less cautious consumers toward cheaper, unregulated compounds bought online. Australia offers a cautionary preview, where a sharp rise in anabolic use among young adults has arrived without clinical guidance, a pattern detailed in reporting on the steroid boom and missing quit guidelines.
There is also the matter of where this all happened. The organizers could have staged a wellness milestone in some restorative setting. They chose Sin City, a place built on living for the moment and letting tomorrow’s bill arrive later, which is a fitting backdrop for a product whose long-term effects are still being argued over.
If the July panel recommends loosening the rules, Enhanced and its rivals get the regulatory tailwind their valuations assume, and the consumer peptide market moves from telehealth niche to mainstream pharmacy aisle within a year. If the panel holds the line or the FDA declines to follow it, a $1.2 billion company is left selling a Vegas memory and a thinner book of approved drugs than its investors are betting on.
Frequently Asked Questions
What are the Enhanced Games?
The Enhanced Games are an athletic competition where participants are permitted, and often encouraged, to use performance-enhancing drugs under medical supervision. The inaugural event was held on May 24, 2026, at Resorts World Las Vegas, with 42 athletes competing in weightlifting, swimming, and track events for prize money.
Is Enhanced Group a publicly traded company?
Yes. Enhanced Group began trading on the New York Stock Exchange under the ticker ENHA on May 8, 2026, after merging with a SPAC called A Paradise Acquisition Corp. The transaction valued the company at $1.2 billion and was expected to deliver up to $200 million in gross cash proceeds.
What is the FDA deciding about peptides in July?
An FDA advisory committee is scheduled to meet on July 23 and 24, 2026, to consider reclassifying several peptides that were restricted in 2023. A favorable recommendation could let compounding pharmacies and sellers offer those substances more openly, though the committee’s vote is advisory and not legally binding.
Are peptides legal to buy in the United States?
Some are and some are not. FDA-approved peptides can be prescribed through licensed providers, while a number of popular compounds such as BPC-157 sit in a legal gray zone after the 2023 restrictions, which is why many users source them through unregulated channels.
Did anyone break a world record at the Enhanced Games?
One athlete did. Greek swimmer Kristian Gkolomeev set a world record in the 50 meter freestyle with a time of 20.81 seconds, beating the previous mark by 0.07 seconds. It was the only world record of the event.
Disclaimer: This article is for informational purposes only and does not constitute medical, financial, or investment advice. Peptides, hormones, and performance-enhancing substances carry health risks, and securities such as ENHA carry investment risk; readers should consult a qualified medical professional and a licensed financial adviser before acting. Figures and dates are accurate as of publication.
